Relapse can have ‘advantages’ in AL amyloidosis

Healio spoke withTaimur Sher, MBBS, MD,a hematologist, internist and oncologist at the Mayo Clinic Cancer and Multispecialty Amyloidosis Center, on assessing the three most important factors in amyloid light chain (AL) amyloidosis patients and how relapses can guide treatment paths.

Click here to watch the next video in the series on how auto-hematopoietic stem cell transplantation has affected treatment outcomes in AL amyloidosis.